Catalent | CTLT - سود ناخالص در فروش



سود ناخالص در فروش تغییر دادن تاریخ
Agilent USD 946M 44M 2025-12
AstraZeneca USD 12.39B 5M 2025-12
Bristol-Myers Squibb USD 8.79B 110M 2025-09
Bruker USD 449.2M 69.8M 2025-12
Centene USD 2.14B 796M 2025-12
Charles River Laboratories USD 271.96M 39.43M 2025-12
Cigna USD 56.45B 50.29B 2025-09
Danaher USD 3.97B 443M 2025-12
Dentsply International USD 443M 2M 2025-12
Elevance Health USD 11.68B 889M 2025-12
Eli Lilly USD 14.59B 1.48B 2025-09
Glaxosmithkline GBP 8.75B 2.92B 2025-09
Hologic USD 586.4M 2.9M 2025-12
Humana USD 4.82B 754M 2025-06
Illumina USD 759M 26M 2025-12
Intuitive Surgical USD 1.9B 241.9M 2025-12
IQVIA Holdings USD 1.12B 32M 2025-12
J&J USD 16.6B 118M 2025-12
Laboratory Of America USD 993.2M 31.9M 2025-12
Lonza CHF 1.29B 248M 2025-06
McKesson USD 3.68B 143M 2025-12
Merck EUR 2.96B 252M 2025-12
Merck USD 13.42B 431M 2025-09
Mettler Toledo International USD 675.44M 65.98M 2025-12
Novartis USD 10.82B 695M 2025-09
Pfizer USD 3.54B 7.61B 2025-09
Quest Diagnostics USD 873M 37M 2025-12
Repligen USD 103.83M 3.32M 2025-12
Revvity USD 421.66M 47.06M 2025-12
Roche Holding CHF 22.09B 10.04B 2025-12
Supernus Pharmaceuticals USD 164.04M 15.23M 2025-12
Thermo Fisher Scientific USD 4.64B 419M 2025-12
UnitedHealth USD 20.64B 77.96B 2025-09
Veradigm USD 83.44M 3.95M 2022-09
Waters USD 557.42M 97.44M 2025-12
West Pharmaceutical Services USD 303.9M 9.6M 2025-12